Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | VCP | P55072 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | SARS1 | P49591 | 1/20 | 0.37 |
| ▸ | AHCY | P23526 | 4/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | EDNRA | P25101 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14393620 | 1.00 | BLM (0.44) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL13645843 | 0.91 | ALDH1A1 (0.44) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL3478702 | 0.86 | MEN1 (0.40) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL14393328 | 0.86 | MEN1 (0.40) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL12374009 | 0.84 | SARS1 (0.40) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL13625720 | 0.84 | BLM (0.45) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL14393416 | 0.84 | BLM (0.45) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL10642386 | 0.73 | CCNE1 (0.51) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL13777714 | 0.70 | MEN1 (0.36) | BLMALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL10643609 | 0.70 | CCNE1 (0.50) | BLMALDH1A1MEN1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090280059-A1 | SUBSTITUTED ARYL PIPERIDINYLALKYNYLADENOSINES AS A2AR AGONISTS | PGXHEALTH, LLC (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090280059-A1 | SUBSTITUTED ARYL PIPERIDINYLALKYNYLADENOSINES AS A2AR AGONISTS | ADORA2A, ADORA1, ADORA3 | BLM 1318/4885ALDH1A1 830/4885MEN1 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.